Reproducibility Initiative

Elizabeth Iorns explains how Science Exchange grew from her frustration with fragmented, inefficient scientific research into a curated marketplace for outsourced experiments. She discusses marketplace development, enterprise adoption, quality control, and how the Reproducibility Initiative helped open pharmaceutical partnerships. For biotech founders, she recommends testing the key scientific hypothesis early, building around shared commitment and strong execution, and treating milestones and risk reduction differently from software product development. She also describes growing opportunities in biotech and how scientists and non-scientists can build companies together.